Skip to main content
MOA Life Plus Co. Ltd. logo

MOA Life Plus Co. Ltd. — Investor Relations & Filings

Ticker · 142760 ISIN · KR7142760008 KO Manufacturing
Filings indexed 361 across all filing types
Latest filing 2025-03-12 Proxy Solicitation & In…
Country KR South Korea
Listing KO 142760

About MOA Life Plus Co. Ltd.

http://moalifeplus.com/

MOA Life Plus Co. Ltd. is a biopharmaceutical company that researches and develops innovative medicines and consumer healthcare products. The company's pharmaceutical division focuses on a pipeline of biopharmaceuticals, including immunotherapies, cancer treatments, and vaccines for infectious diseases. A core platform technology utilizes Gamma-Polyglutamic Acid (γ-PGA), a natural amino acid polymer derived from fermented foods, to enhance immune responses and serve as a vaccine adjuvant. The consumer business division provides tailored healthcare solutions for immunity enhancement, skin rejuvenation, and pet care. It also manufactures and supplies γ-PGA-based raw materials for the cosmetics industry.

Recent filings

Filing Released Lang Actions
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea (often filed under the 'Proxy Solicitation' category). It contains information regarding the upcoming Annual General Meeting (AGM), including the agenda, voting procedures, and financial statements (both consolidated and separate) for the fiscal year 2024. Since it is a formal solicitation of proxies for a shareholder meeting, it falls under the 'Proxy Solicitation & Information Statement' category.
2025-03-12 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Notice of Annual General Meeting' (주주총회소집공고) for 'Moa Life Plus Co., Ltd.' (주식회사 모아라이프플러스). It contains the meeting date, location, agenda items (reporting and voting matters), and information regarding electronic voting and proxy solicitation. This document is a standard proxy statement/notice sent to shareholders to inform them of the upcoming AGM and solicit their votes, which falls under the 'Proxy Solicitation & Information Statement' category.
2025-03-12 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (Moa Life Plus) announcing a significant change in financial structure (revenue or profit/loss change of 30% or more). This is a standard regulatory disclosure requirement in the Korean market (DART system) for material financial events. It provides specific financial data and reasons for the change, fitting the definition of a general regulatory announcement that does not constitute a full annual report or a simple report publication notice. FY 2024
2025-02-27 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a formal regulatory disclosure regarding a 'Single Sales/Supply Contract' (단일판매ㆍ공급계약체결) filed by the company Moa Life Plus. It details the contract value, counterparty, duration, and payment terms. Since this is a specific regulatory announcement of a material business event (a supply contract) that does not fit into categories like financial reports, dividends, or management changes, it falls under the general regulatory filing category.
2025-02-14 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a formal regulatory disclosure regarding a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결) filed by Moa Life Plus. It details the contract value, counterparty, duration, and payment terms. Since this is a specific material event disclosure that does not fit into categories like M&A, dividends, or share issues, it falls under the general regulatory filing category.
2025-02-04 Korean
전환가액의조정
Capital/Financing Update Classification · 95% confidence The document is a formal regulatory filing from a Korean company (Moa Life Plus) regarding the 'Adjustment of Conversion Price' (전환가액의 조정) for convertible bonds. This type of filing details changes to the capital structure, specifically the conversion price and the number of shares issuable upon conversion due to market price fluctuations. This falls under the category of capital structure changes and financing updates, which is best classified as 'CAP' (Capital/Financing Update).
2025-01-02 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.